Efficacy and Safety of Baxdrostat in Participants with CKD and Uncontrolled Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial.

Journal:

Journal of the American Society of Nephrology

Published:

2025-09-07

DOI:

10.1681/asn.0000000849

Affiliations:

7

Authors:

8

Go to article

Institutions	Authors	Share
AstraZeneca Gaithersburg, MD, United States of America (USA)	4.000000	0.50
Stanford University School of Medicine, United States of America (USA)	1.000000	0.13
The University of Utah (Utah), United States of America (USA)	1.000000	0.13
AstraZeneca Sweden, Sweden	1.000000	0.13
The George Institute for Global Health (TGI), Australia	0.500000	0.06
University Medical Center Groningen (UMCG), RUG, Netherlands	0.500000	0.06

Interested in Nutrition and Dietetics?